Inhibitory Effects of Boesenbergia pandurata on Age-Related Periodontal Inflammation and Alveolar Bone Loss in Fischer 344 Rats

J Microbiol Biotechnol. 2018 Mar 28;28(3):357-366. doi: 10.4014/jmb.1711.11034.

Abstract

Periodontitis, an infective disease caused by oral pathogens and the intrinsic aging process, results in the destruction of periodontal tissues and the loss of alveolar bone. This study investigated whether Boesenbergia pandurata extract (BPE) standardized with panduratin A exerted anti-periodontitis effects, using an aging model representative of naturally occurring periodontitis. In aged rats, the oral administration of BPE (200 mg·kg-1·day-1) for 8 weeks significantly reduced the mRNA and protein expression of interleukin-1β, nuclear factor-kappa B, matrix metalloproteinase (MMP)-2, and MMP-8 in gingival tissues (p < 0.01). In alveolar bone, histological analysis with staining and micro-computed tomography revealed the attenuation of alveolar bone resorption in the BPE-treated aged group, which led to a significant reduction in the mRNA and protein expression of nuclear factor of activated T-cells c1 (NFATc1), c-Fos, tartrate-resistant acid phosphatase, and cathepsin K (p < 0.01). BPE not only increased the expression of osteoblast differentiation markers, such as alkaline phosphate, and collagen type I (COL1A1), but also increased the ratio of osteoprotegerin to RANKL. Collectively, the results strongly suggested that BPE is a natural resource for the prevention or treatment of periodontal diseases.

Keywords: Boesenbergia pandurata; age-related periodontitis; bone resorption; gingival inflammation.

MeSH terms

  • Alveolar Bone Loss / diagnostic imaging
  • Alveolar Bone Loss / drug therapy*
  • Alveolar Bone Loss / pathology
  • Alveolar Bone Loss / prevention & control
  • Animals
  • Cathepsin K / metabolism
  • Collagen Type I / metabolism
  • Collagen Type I, alpha 1 Chain
  • Gingiva / metabolism
  • Inflammation / drug therapy*
  • Inflammation / prevention & control
  • Interleukin-1beta / metabolism
  • Male
  • Matrix Metalloproteinase 2 / metabolism
  • Matrix Metalloproteinase 8 / metabolism
  • Models, Animal
  • NF-kappa B / metabolism
  • Osteoporosis / diagnostic imaging
  • Osteoporosis / drug therapy*
  • Osteoporosis / pathology
  • Osteoporosis / prevention & control
  • Osteoprotegerin / metabolism
  • Periodontal Diseases / drug therapy*
  • Periodontal Diseases / pathology
  • Periodontal Diseases / prevention & control
  • Periodontitis / diagnostic imaging
  • Periodontitis / drug therapy
  • Periodontitis / prevention & control
  • Plant Extracts / administration & dosage
  • Plant Extracts / pharmacology*
  • Plant Extracts / therapeutic use
  • Proto-Oncogene Proteins c-fos / metabolism
  • RANK Ligand / metabolism
  • RNA, Messenger / biosynthesis
  • Rats
  • Rats, Inbred F344
  • Tartrate-Resistant Acid Phosphatase / metabolism
  • Transcription Factors / metabolism
  • X-Ray Microtomography
  • Zingiberaceae / chemistry*

Substances

  • Collagen Type I
  • Collagen Type I, alpha 1 Chain
  • Interleukin-1beta
  • NF-kappa B
  • NFATC1 protein, rat
  • Osteoprotegerin
  • Plant Extracts
  • Proto-Oncogene Proteins c-fos
  • RANK Ligand
  • RNA, Messenger
  • Tnfrsf11b protein, rat
  • Transcription Factors
  • Tartrate-Resistant Acid Phosphatase
  • Cathepsin K
  • Ctsk protein, rat
  • Matrix Metalloproteinase 2
  • Matrix Metalloproteinase 8
  • Mmp8 protein, rat